The World Health Organization estimates that 10 million Americans, and six percent of the world population suffer from either chronic or episodic Fibromyalgia. First recognized by the AMA in 1987, the specific collection of symptoms was not recognized as a syndrome for nearly 20 years, and is still not universally recognized by healthcare providers. In as much as the medical community has progressed in the diagnosis and assessment of Fibro, the management and treatment of this debilitating condition has made relatively little headway.
Every month or so it seems that another miracle treatment for Fibro is being advertised on the Internet. Practitioners should make no mistake; there are some treatments that help some people, and some of these experience phenomenal results. That is not the issue. The other side of that truth is that there is no one treatment that helps everyone.
While we live in a rapidly advancing society, our expectations often lead us to believe we are advancing in every realm. This is frustratingly untrue. As stressors increase, personal contact decreases and healthcare becomes diluted and overstretched, we are forced to consider the fact that we might not be doing quite enough to address chronic and invisible illness and support those suffering these painful conditions. We can do better. And we will.